coust-doli

coust-doli

Illustration of Lysopaine boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM

  • Product Code
  • ILEA003436038
  • Registered date
  • 2024/10/11 00:00:00
  • Credit
  • Abaca Press / Kyodo News Images
  • Media source
  • Coust Laurent/ABACA
  • Media size
  • 4207 × 2805 pixel
  • Resolution
  • 300 dpi
  • Deployment size
  • 2.67(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Sanofi Group To Sell Doliprane To US Fund

    Sanofi Group To Sell Doliprane To US Fund

    Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
      Sanofi Group To Sell Doliprane To US Fund

      Sanofi Group To Sell Doliprane To US Fund

      Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
        Sanofi Group To Sell Doliprane To US Fund

        Sanofi Group To Sell Doliprane To US Fund

        Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
          Sanofi Group To Sell Doliprane To US Fund

          Sanofi Group To Sell Doliprane To US Fund

          Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
            Sanofi Group To Sell Doliprane To US Fund

            Sanofi Group To Sell Doliprane To US Fund

            Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
              Politics At MED9 Summit - Cyprus

              Politics At MED9 Summit - Cyprus

              (L-R) Italy's Prime Minister Giorgia Meloni, Malta's Prime Minister Robert Abela, Spain's Prime Minister Pedro Sanchez, European Commission President Ursula von der Leyen, Jordan's King Abdullah II, Cyprus' President Nikos Christodoulides, France's President Emmanuel Macron, Croatia's President Zoran Milanovic, Greece's Prime Minister Kyriakos Mitsotakis, Slovenia's Prime Minister Robert Golob, and Portugal's Foreign Minister Paulo Rangelas pose for a group picture during the MED9 Summit in Paphos, Cyprus on October 11, 2024. Leaders from nine European countries around the Mediterranean Sea met in Cyprus on October 11 to discuss the wars in the Middle East, which they fear will fuel migration and threaten their own security. Photo by Pool Moncloa/Fernando Calvo/Europa Press/ABACAPRESS.COM
                Politics At MED9 Summit - Cyprus

                Politics At MED9 Summit - Cyprus

                (L-R) Spain's Prime Minister Pedro Sanchez, European Commission President Ursula von der Leyen, Jordan's King Abdullah II, Cyprus' President Nikos Christodoulides and France's President Emmanuel Macron pose for a group picture during the MED9 Summit in Paphos, Cyprus on October 11, 2024. Leaders from nine European countries around the Mediterranean Sea met in Cyprus on October 11 to discuss the wars in the Middle East, which they fear will fuel migration and threaten their own security. Photo by Pool Moncloa/Fernando Calvo/Europa Press/ABACAPRESS.COM
                  Sanofi Group To Sell Doliprane To US Fund

                  Sanofi Group To Sell Doliprane To US Fund

                  Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
                    Sanofi Group To Sell Doliprane To US Fund

                    Sanofi Group To Sell Doliprane To US Fund

                    Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
                      Sanofi Group To Sell Doliprane To US Fund

                      Sanofi Group To Sell Doliprane To US Fund

                      Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM